Company intelligence / Profile preview

FPCI BioMedTech

Paris, France

Ownership: Private
Development stage: Other

Overview

FPCI BioMedTech is a French professional private equity investment fund (FPCI) managed by Truffle Capital. The fund specifically targets early-stage and late-stage investments in the life sciences sector, with a primary focus on medical devices, biotechnology, and digital health innovations. By providing capital and strategic guidance, the fund aims to support the development of breakthrough medical technologies from proof-of-concept through to clinical validation and market entry. Its portfolio typically includes companies developing minimally invasive surgical tools, innovative implants, and therapeutic platforms.

Industry: Investors

Beyond the preview

Go deeper on FPCI BioMedTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FPCI BioMedTech.

Explore the full profile